Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia [Phase 2]
Phase 2 clinical trial investigating dual modulation of sigma-1 and NMDA receptors for schizophrenia, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Digital Strategies to Advance Help-Seeking - Aim 3 [NA]
A Columbia University trial update describes Aim 3 of a digital strategy study to promote help-seeking among individuals at clinical high ri…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Brain Imaging of Cognition Inn Schizophrenia and Depression
A recruiting clinical trial at The Royal Ottawa Mental Health Centre is studying brain imaging and cognition in individuals with schizophren…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder [NA]
This clinical trial investigates improving health literacy among patients with schizophrenia spectrum disorders, and it is currently not yet…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Safety and Feasibility of Nasal Delivery of Human Dental Follicle Mesenchymal Stem Cell-Derived Exosomes for Negative Symptoms in Treatment-Resistant Schizophrenia: A Pilot Study [EARLY_Phase 1]
A Phase 1 pilot study assessing the safety and feasibility of nasal delivery of exosomes derived from human dental follicle mesenchymal stem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Evaluate Pharmacokinetics, Safety, and Tolerability of AX251 LAI in Patients With Schizophrenia [Phase 1]
This entry outlines a Phase 1 clinical trial to evaluate the pharmacokinetics, safety, and tolerability of AX251 LAI in patients with schizo…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia [Phase 2]
A Phase 2 clinical trial update describing the safety, tolerability, and treatment response study of GXV813 in hospitalized adults with schi…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Cromoglicate Adjunctive Therapy for Outpatients With Schizophrenia [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating cromoglicate as adjunctive therapy for outpatients with schizophrenia, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Cerebellar Stimulation and Cognitive Control [NA]
A clinical trial update notes that a cerebellar stimulation study assessing cognitive control is currently recruiting, with conditions inclu…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders
This clinical trial update describes a study evaluating ultra-high-field MRI biomarkers combined with visual perception assessment to improv…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Tolerability of MDMA in Schizophrenia [Phase 1, Phase 2]
This clinical trial update describes an ongoing Phase 1/Phase 2 study evaluating the tolerability of MDMA in adults with schizophrenia, curr…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Schizophrenia [Phase 3]
Phase 3 clinical trial update evaluating KarXT for acutely psychotic schizophrenia in Japanese adults; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Cerebellar Modulation of Cognition in Psychosis [NA]
This clinical trial update shows a study on cerebellar modulation of cognition in psychosis that is currently recruiting. The study covers s…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients [Phase 3]
This Phase 3 clinical trial is recruiting to test whether metformin can alleviate statin-induced abnormal glucose metabolism in patients wit…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Impact of Cannabis Consumption on Psychotic Symptoms and Reality Monitoring in Patients With Schizophrenia: a Real-life Study [Phase 1, Phase 2]
A real-life Phase 1/2 study investigating how cannabis consumption influences psychotic symptoms and reality monitoring in patients with sch…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study [NA]
A Rutgers-led clinical trial studying decision-making in schizophrenia using neuroimaging and experience sampling; recruitment is currently …
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia [Phase 3]
This document reports an extension Phase 3 trial to evaluate the long-term safety and tolerability of adjunctive KarXT for schizophrenia; re…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Feasibility, Acceptability, and Preliminary Efficacy of Yoga-based Group Intervention for Outpatients With Schizophrenia Spectrum Disorders [NA]
This clinical trial update assesses the feasibility, acceptability, and preliminary efficacy of a yoga-based group intervention for outpatie…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Volunteers
This clinical trial update describes ongoing brain imaging studies in childhood-onset psychiatric and endocrine disorders, along with health…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Time and Virtual Reality in Schizophrenia and Bipolar Disorder [NA]
A clinical trial evaluating time and virtual reality interventions for schizophrenia and bipolar disorder is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
A recruiting clinical trial evaluating biomarkers and biotypes, disease course in early psychosis, and specialty services for schizophrenia-…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Vaping and Smoking Project in People With Schizophrenia [NA]
A clinical trial is recruiting to compare acute abstinence from cigarettes versus electronic cigarettes (ENDS) in people with schizophrenia.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Deep Brain Stimulation in Treatment Resistant Schizophrenia [NA]
Johns Hopkins is recruiting participants for a deep brain stimulation trial targeting treatment-resistant schizophrenia.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia [Phase 2]
A Phase 2 clinical trial evaluating ML-007C-MA for schizophrenia in inpatient adults is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Prebiotic Treatment in People With Schizophrenia [NA]
This clinical trial update notes an ongoing study evaluating a prebiotic treatment in individuals with schizophrenia and schizoaffective dis…